Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
65 hedge funds and large institutions have $41.6M invested in Genesis Healthcare, Inc. in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
89% more capital invested
Capital invested by funds: $22.1M → $41.6M (+$19.5M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
7% more funds holding
Funds holding: 61 → 65 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$7.56M |
| 2 |
FWC
First Washington Corp
Seattle,
Washington
|
+$2.46M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$375K |
| 4 |
Renaissance Technologies
New York
|
+$241K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
-$1.72M |
| 2 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$786K |
| 3 |
SIM
Spark Investment Management
New York
|
-$686K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$444K |
| 5 |
Goldman Sachs
New York
|
-$293K |
GEN Hedge Fund Activity: Q3 2016 in Review
65 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2016, worth a combined $41.6M — up 89% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GEN positions and 7 closed out — a net gain of 4 holders — while 21 added to existing stakes and 17 trimmed.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $7.56M. The largest seller was Cannell Capital, exiting entirely with an estimated $1.72M sold.
- 65 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q3 2016, up from 61 in Q2 2016.
- Funds reported $41.6M of Genesis Healthcare, Inc. stock for Q3 2016, up 89% quarter-over-quarter.
- 11 funds opened new Genesis Healthcare, Inc. positions in Q3 2016 and 7 closed out, a net change of +4 holders.
- The largest Genesis Healthcare, Inc. buyer in Q3 2016 was HighTower Advisors, an estimated $7.56M added.
- The largest Genesis Healthcare, Inc. seller in Q3 2016 was Cannell Capital, an estimated $1.72M sold.
Based on aggregated 13F filings for Q3 2016.